Literature DB >> 29986543

Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Anagha Bhakay1, Mahbubur Rahman2, Rajesh N Dave3, Ecevit Bilgili4.   

Abstract

Drug nanoparticles embedded in a dispersant matrix as a secondary phase, i.e., drug-laden nanocomposites, offer a versatile delivery platform for enhancing the dissolution rate and bioavailability of poorly water-soluble drugs. Drug nanoparticles are prepared by top-down, bottom-up, or combinative approaches in the form of nanosuspensions, which are subsequently dried to prepare drug-laden nanocomposites. In this comprehensive review paper, the term “nanocomposites” is used in a broad context to cover drug nanoparticle-laden intermediate products in the form of powders, cakes, and extrudates, which can be incorporated into final oral solid dosages via standard pharmaceutical unit operations, as well as drug nanoparticle-laden strip films. The objective of this paper is to review studies from 2012⁻2017 in the field of drug-laden nanocomposites. After a brief overview of the various approaches used for preparing drug nanoparticles, the review covers drying processes and dispersant formulations used for the production of drug-laden nanocomposites, as well as various characterization methods including quiescent and agitated redispersion tests. Traditional dispersants such as soluble polymers, surfactants, other water-soluble dispersants, and water-insoluble dispersants, as well as novel dispersants such as wet-milled superdisintegrants, are covered. They exhibit various functionalities such as drug nanoparticle stabilization, mitigation of aggregation, formation of nanocomposite matrix⁻film, wettability enhancement, and matrix erosion/disintegration. Major challenges such as nanoparticle aggregation and poor redispersibility that cause inferior dissolution performance of the drug-laden nanocomposites are highlighted. Literature data are analyzed in terms of usage frequency of various drying processes and dispersant classes. We provide some engineering considerations in comparing drying processes, which could account for some of the diverging trends in academia vs. industrial practice. Overall, this review provides rationale and guidance for drying process selection and robust nanocomposite formulation development, with insights into the roles of various classes of dispersants.

Entities:  

Keywords:  BCS Class II drugs; aggregates; dissolution enhancement; drug nanosuspensions; formulation; nanocomposites; redispersion

Year:  2018        PMID: 29986543      PMCID: PMC6160929          DOI: 10.3390/pharmaceutics10030086

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  182 in total

Review 1.  Spray drying technique. I: Hardware and process parameters.

Authors:  Krzysztof Cal; Krzysztof Sollohub
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

2.  Development of a discriminative biphasic in vitro dissolution test and correlation with in vivo pharmacokinetic studies for differently formulated racecadotril granules.

Authors:  Jia Deng; Sven Staufenbiel; Shilei Hao; Bochu Wang; Andriy Dashevskiy; Roland Bodmeier
Journal:  J Control Release       Date:  2017-04-25       Impact factor: 9.776

3.  Preparation and solidification of redispersible nanosuspensions.

Authors:  Xin Zhang; Jian Guan; Rui Ni; Luk Chiu Li; Shirui Mao
Journal:  J Pharm Sci       Date:  2014-05-19       Impact factor: 3.534

4.  Development of a nanosuspension for iv administration: From miniscale screening to a freeze dried formulation.

Authors:  Kerstin J Frank; Georg Boeck
Journal:  Eur J Pharm Sci       Date:  2016-03-09       Impact factor: 4.384

5.  Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications.

Authors:  Annika Tuomela; Timo Laaksonen; Johanna Laru; Osmo Antikainen; Juha Kiesvaara; Jukka Ilkka; Olli Oksala; Seppo Rönkkö; Kristiina Järvinen; Jouni Hirvonen; Leena Peltonen
Journal:  Int J Pharm       Date:  2015-03-05       Impact factor: 5.875

6.  Drug nanocrystals - Versatile option for formulation of poorly soluble materials.

Authors:  Leena Peltonen; Jouni Hirvonen
Journal:  Int J Pharm       Date:  2017-12-17       Impact factor: 5.875

7.  Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?

Authors:  Ecevit Bilgili; Meng Li; Afolawemi Afolabi
Journal:  Pharm Dev Technol       Date:  2015-03-16       Impact factor: 3.133

8.  Nanonized itraconazole powders for extemporary oral suspensions: Role of formulation components studied by a mixture design.

Authors:  Andrea Foglio Bonda; Maurizio Rinaldi; Lorena Segale; Luca Palugan; Matteo Cerea; Carlo Vecchio; Franco Pattarino
Journal:  Eur J Pharm Sci       Date:  2015-12-30       Impact factor: 4.384

Review 9.  Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.

Authors:  David P Elder; René Holm; Heidi Lopez de Diego
Journal:  Int J Pharm       Date:  2012-11-24       Impact factor: 5.875

Review 10.  Performance Parameters and Characterizations of Nanocrystals: A Brief Review.

Authors:  Manasi M Chogale; Vinod N Ghodake; Vandana B Patravale
Journal:  Pharmaceutics       Date:  2016-08-30       Impact factor: 6.321

View more
  22 in total

1.  New Borane-Protected Derivatives of α-Aminophosphonous Acid as Anti-Osteosarcoma Agents: ADME Analysis and Molecular Modeling, In Vitro Studies on Anti-Cancer Activities, and NEP Inhibition as a Possible Mechanism of Anti-Proliferative Activity.

Authors:  Magdalena Mizerska-Kowalska; Sylwia Sowa; Beata Donarska; Wojciech Płaziński; Adrianna Sławińska-Brych; Aleksandra Tomasik; Anna Ziarkowska; Krzysztof Z Łączkowski; Barbara Zdzisińska
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

2.  Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation.

Authors:  Yuanfen Liu; Yuqi Li; Pengcheng Xu; Yan Shen; Baoqiang Tang; Qiyue Wang
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

3.  Facile production of quercetin nanoparticles using 3D printed centrifugal flow reactors.

Authors:  Davide De Grandi; Alireza Meghdadi; Gareth LuTheryn; Dario Carugo
Journal:  RSC Adv       Date:  2022-07-19       Impact factor: 4.036

4.  Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability.

Authors:  Haroon Rahim; Abdul Sadiq; Riaz Ullah; Ahmed Bari; Fazli Amin; Umar Farooq; Naeem Ullah Jan; Hafiz Majid Mahmood
Journal:  Int J Nanomedicine       Date:  2020-11-17

5.  Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation.

Authors:  Dalia A Gaber
Journal:  Int J Nanomedicine       Date:  2020-06-17

Review 6.  Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.

Authors:  Maria Rosa Gigliobianco; Cristina Casadidio; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2018-08-21       Impact factor: 6.321

7.  Adapalene-loaded poly(ε-caprolactone) microparticles: Physicochemical characterization and in vitro penetration by photoacoustic spectroscopy.

Authors:  Jessica Mendes Nadal; Guilherme Dos Anjos Camargo; Andressa Novatski; William Roger Macenhan; Daniele Toniolo Dias; Fernanda Malaquias Barboza; Amanda Lyra; João Ricardo Roik; Josiane Padilha de Paula; Aloisi Somer; Paulo Vitor Farago
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

8.  Electrostatic Precipitation of Submicron Particles in a Molten Carrier.

Authors:  Adrian Dobrowolski; Damian Pieloth; Helmut Wiggers; Markus Thommes
Journal:  Pharmaceutics       Date:  2019-06-13       Impact factor: 6.321

9.  Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.

Authors:  Haroon Rahim; Abdul Sadiq; Shahzeb Khan; Fazli Amin; Riaz Ullah; Abdelaaty A Shahat; Hafiz Majid Mahmood
Journal:  Int J Nanomedicine       Date:  2019-08-06

Review 10.  Immunological and Toxicological Considerations for the Design of Liposomes.

Authors:  Collin T Inglut; Aaron J Sorrin; Thilinie Kuruppu; Shruti Vig; Julia Cicalo; Haroon Ahmad; Huang-Chiao Huang
Journal:  Nanomaterials (Basel)       Date:  2020-01-22       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.